By Counterforce Health Team in Defitelio (defibrotide) —

How to Get Defitelio (Defibrotide) Covered by Humana in Ohio: Prior Authorization, Appeals, and Cost-Saving Strategies

Answer Box: Getting Defitelio Covered by Humana in Ohio

Defitelio (defibrotide) requires prior authorization from Humana Medicare Advantage plans in Ohio. Your prescriber must submit medical necessity documentation proving hepatic veno-occlusive disease (VOD) or sinusoidal obstruction syndrome (SOS) post-HSCT with supporting labs and clinical notes. If denied, you have 65 days to appeal internally, then 180 days for Ohio's external review through the Department of Insurance. First step today: Have your transplant team contact Humana's prior authorization department at 1-877-486-2621 to request the Defitelio PA form and begin the medical necessity review.

Table of Contents

  1. What Drives Defitelio Costs with Humana
  2. Benefit Investigation: What to Ask Humana
  3. Patient Assistance and Cost Support Options
  4. Prior Authorization: Step-by-Step Process
  5. Specialty Pharmacy Coordination
  6. Appeals Process in Ohio
  7. Annual Coverage Changes and Budgeting
  8. Conversation Scripts and Templates
  9. FAQ: Common Questions
  10. Sources and Further Reading

What Drives Defitelio Costs with Humana

Defitelio (defibrotide sodium) is a high-cost specialty infusion drug used for severe hepatic veno-occlusive disease following hematopoietic stem cell transplantation. Understanding how Humana structures coverage helps you navigate the approval process more effectively.

Coverage Structure and Tiering

Formulary Status: Defitelio requires prior authorization under Humana Medicare Advantage plans, with policies effective through 2026. The drug typically falls into higher specialty tiers (Tier 4 or 5) due to its high cost and limited alternatives.

Key Cost Factors:

  • Prior Authorization: Required for all Humana plans covering Defitelio
  • Specialty Tier Placement: Higher copays/coinsurance than standard medications
  • Site of Care: Hospital-based infusion affects coverage pathway (Part B vs. Part D)
  • Quantity Limits: Restricted to FDA-approved dosing protocols
Note: Humana announced plans to reduce prior authorization requirements by one-third by 2026, but specialty drugs like Defitelio will likely retain PA requirements due to cost and safety considerations.

Benefit Investigation: What to Ask Humana

Before starting treatment, gather specific coverage details to avoid surprises. Call the number on your Humana ID card or log into your MyHumana account.

Essential Questions for Humana

Coverage Verification:

  • "Is Defitelio covered under my specific plan for 2024?"
  • "What tier is Defitelio on, and what's my copay/coinsurance?"
  • "Does my plan require prior authorization for Defitelio?"
  • "Are there quantity limits or step therapy requirements?"

Process Details:

  • "What documentation does my doctor need to submit?"
  • "How long does the PA review typically take?"
  • "Can we request expedited review for urgent cases?"
  • "Which specialty pharmacies are in-network for Defitelio?"

Information to Record

Keep detailed notes including:

  • Representative name and reference number
  • Specific coverage determination
  • Required forms and submission methods
  • Timeline expectations
  • Appeal rights and deadlines

Patient Assistance and Cost Support Options

Several programs can help reduce out-of-pocket costs for Defitelio, though eligibility varies by insurance type.

JazzCares Patient Assistance Program

Free Drug Program Eligibility:

Enrollment Process:

  1. Prescriber completes JazzCares Enrollment Form (Sections 1-7)
  2. Patient provides insurance cards and income proof
  3. Submit signed forms via fax to 1-855-593-3955
  4. Call 1-833-533-JAZZ (5299) for assistance
Important: Medicare patients are generally ineligible for copay assistance programs but may qualify for the free drug program if coverage is denied.

Additional Support Resources

Ohio-Specific Resources:

  • Ohio Department of Insurance Consumer Services: 1-800-686-1526
  • OSHIIP (Ohio Senior Health Insurance Information Program) for Medicare questions
  • UHCAN Ohio for consumer advocacy and appeals assistance

Prior Authorization: Step-by-Step Process

Getting Defitelio approved requires careful documentation of medical necessity, particularly for post-HSCT hepatic VOD/SOS.

Step 1: Gather Required Documentation

Clinical Evidence Needed:

  • HSCT procedure records and dates
  • Hepatic VOD/SOS diagnosis with ICD-10 codes
  • Laboratory values showing renal or pulmonary dysfunction
  • Documentation of symptom onset post-transplant
  • Prior treatment attempts and outcomes

Step 2: Submit Prior Authorization Request

Submission Methods:

  • Fax: 1-877-486-2621 with completed PA form
  • Phone: Call Clinical Pharmacy Review at 1-800-555-2546
  • Online: Through Humana provider portal

Timeline Expectations:

  • Standard review: Up to 30 days
  • Expedited review: 72 hours for urgent cases
  • Notification sent to prescriber and patient

Step 3: Medical Necessity Letter Requirements

Your transplant team should include:

  • Specific diagnosis and severity markers
  • Timeline of HSCT to VOD/SOS onset
  • Clinical rationale for Defitelio vs. supportive care
  • Expected treatment duration and monitoring plan
  • Contraindications to alternative approaches
Clinician Corner: Include references to FDA labeling for Defitelio's approved indication and any relevant transplant center protocols. Document bleeding risk assessment and monitoring plans, as coagulopathy concerns are common denial reasons.

Specialty Pharmacy Coordination

Defitelio requires specialized handling and coordination through Humana's specialty pharmacy network rather than standard retail pharmacies.

Network Options

Primary Specialty Pharmacies:

Coordination Process:

  1. Post-PA approval, enroll with specialty pharmacy
  2. Schedule delivery 7-10 days for initial order
  3. Coordinate with hospital infusion center
  4. Monitor for refill timing (typically 5-7 days for subsequent orders)

Site of Care Considerations

Hospital-Based Infusion:

  • May fall under Medicare Part B (medical benefit) rather than Part D
  • Different prior authorization pathway
  • Coordinate with hospital's buy-and-bill procedures
  • Verify coverage pathway before treatment initiation

Appeals Process in Ohio

If Humana denies coverage for Defitelio, Ohio provides multiple appeal levels with specific timelines and procedures.

Internal Appeals with Humana

First Level - Redetermination:

  • Deadline: 65 days from denial notice
  • Timeline: Humana decides within 7 calendar days for Part D
  • Submission: Use Humana's appeal form or written request
  • Required: Copy of denial letter, additional medical records, prescriber statement

Expedited Appeals:

  • Available for urgent medical situations
  • 72-hour decision timeline
  • Mark submissions "EXPEDITED" clearly

Ohio External Review Process

If internal appeals fail, Ohio law provides independent external review through certified Independent Review Organizations (IROs).

External Review Rights:

  • Deadline: 180 days from final internal denial
  • Process: Submit request to health plan, which notifies Ohio Department of Insurance
  • Timeline: 30 days for standard review, 72 hours for expedited
  • Authority: Ohio Department of Insurance oversees process

How External Review Works:

  1. Request form submitted to Humana
  2. Humana forwards to Ohio Department of Insurance
  3. Independent medical experts review case
  4. Decision is binding on Humana if overturned
Ohio Advantage: Even if Humana claims your case isn't eligible for external review, the Ohio Department of Insurance can independently determine eligibility and order a review.

Annual Coverage Changes and Budgeting

Plan ahead for potential coverage changes that could affect Defitelio access and costs.

What Can Change Annually

Formulary Updates:

  • Tier placement modifications
  • Prior authorization requirements
  • Preferred pharmacy networks
  • Quantity limit adjustments

Budget Planning Tips:

  • Review Annual Notice of Changes each October
  • Confirm specialty pharmacy networks remain in-network
  • Update patient assistance program enrollment if needed
  • Consider plan switching during Open Enrollment if coverage deteriorates

Conversation Scripts and Templates

Script: Calling Humana for Coverage Verification

"Hello, I'm calling to verify coverage for Defitelio, spelled D-E-F-I-T-E-L-I-O, for my [relationship to patient] who has [member ID]. We need to confirm prior authorization requirements, tier placement, and in-network specialty pharmacies. Can you also tell me the expected timeline for PA decisions?"

Email Template: Requesting Clinical Documentation

"Dr. [Name], we're preparing a prior authorization request for Defitelio coverage through Humana. Could you please provide: 1) HSCT procedure notes, 2) VOD/SOS diagnosis documentation with ICD-10 codes, 3) current lab values showing organ dysfunction, and 4) your clinical assessment supporting Defitelio medical necessity? The PA form requires submission within [timeframe]."

Peer-to-Peer Request Script for Clinic Staff

"I'm calling to request a peer-to-peer review for a Defitelio prior authorization denial. The patient has documented hepatic VOD with renal dysfunction post-HSCT, and our transplant specialist would like to discuss the medical necessity with your reviewing physician. When can we schedule this discussion?"

FAQ: Common Questions

Q: How long does Humana's prior authorization take for Defitelio? A: Standard review takes up to 30 days, but expedited review is available within 72 hours for urgent cases. Most transplant-related requests qualify for expedited processing.

Q: What if Defitelio isn't on Humana's formulary? A: You can request a formulary exception with medical necessity documentation. The prescriber must demonstrate that all formulary alternatives are ineffective or cause adverse reactions.

Q: Can I appeal if step therapy is required? A: Yes, you can request a step therapy exception if your doctor provides evidence that preferred alternatives have failed or are contraindicated for your specific condition.

Q: Does Humana cover off-label use of Defitelio? A: Coverage for off-label use (such as VOD prophylaxis) is more challenging but possible with strong medical necessity documentation and peer-reviewed evidence.

Q: What happens if I'm hospitalized out-of-state and need Defitelio? A: Emergency coverage typically applies, but coordinate with Humana's case management team immediately to ensure continued coverage and proper billing procedures.

Q: Are there quantity limits for Defitelio? A: Yes, Humana typically limits quantities to FDA-approved dosing protocols (6.25 mg/kg every 6 hours for 21 days minimum). Extensions require additional medical justification.

Counterforce Health helps patients, clinicians, and specialty pharmacies get prescription drugs approved by turning insurance denials into targeted, evidence-backed appeals. The platform ingests denial letters, plan policies, and clinical notes, then identifies the denial basis and drafts point-by-point rebuttals aligned to the plan's own rules. For complex cases like Defitelio approvals, Counterforce Health can help streamline the prior authorization and appeals process with payer-specific workflows and automated documentation.

From our advocates: We've seen Defitelio approvals succeed when transplant teams provide detailed timelines showing rapid VOD progression post-HSCT, supported by trending bilirubin and creatinine levels. The key is demonstrating that supportive care alone is insufficient and that Defitelio represents the standard of care for severe cases. This composite approach has helped multiple patients access treatment through both initial approvals and successful appeals.

When dealing with Counterforce Health's experience, many Defitelio cases involve coordination between transplant centers and specialty pharmacies, making documentation and timing critical for approval success.

Sources and Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies vary by plan and individual circumstances. Always consult with your healthcare provider and insurance plan directly for personalized guidance. For additional help with insurance appeals in Ohio, contact the Ohio Department of Insurance Consumer Services Division at 1-800-686-1526.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.